Annual Total Long Term Liabilities
$0.00
$0.000.00%
31 December 2023
Summary:
Protagenic Therapeutics annual total long term liabilities is currently $0.00, unchanged on 31 December 2023. During the last 3 years, it has fallen by -$1.37 million (-100.00%). PTIX annual total long term liabilities is now -100.00% below its all-time high of $3.79 million, reached on 31 July 2004.PTIX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 September 2024
Summary:
Protagenic Therapeutics quarterly total long term liabilities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.PTIX quarterly long term liabilities is now -100.00% below its all-time high of $19.21 million, reached on 30 June 2008.PTIX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | 0.0% | 0.0% |
3 y3 years | -100.0% | -100.0% |
5 y5 years | 0.0% | 0.0% |
PTIX Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -100.0% | -100.0% | ||
5 y | 5 years | -100.0% | -100.0% | ||
alltime | all time | -100.0% | -100.0% |
Protagenic Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $0.00(0.0%) |
June 2024 | - | $0.00(0.0%) |
Mar 2024 | - | $0.00(0.0%) |
Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2023 | - | $0.00(0.0%) |
June 2023 | - | $0.00(0.0%) |
Mar 2023 | - | $0.00(0.0%) |
Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2022 | - | $318.80 K(+8.7%) |
June 2022 | - | $293.30 K(-0.6%) |
Mar 2022 | - | $295.10 K(-7.3%) |
Dec 2021 | $318.40 K(-76.8%) | $318.40 K(-43.4%) |
Sept 2021 | - | $562.10 K(-15.0%) |
June 2021 | - | $661.40 K(-56.7%) |
Mar 2021 | - | $1.53 M(+11.2%) |
Dec 2020 | $1.37 M(+391.7%) | $1.37 M(+4.8%) |
Sept 2020 | - | $1.31 M(+15.6%) |
June 2020 | - | $1.13 M(+107.1%) |
Mar 2020 | - | $547.50 K(+96.0%) |
Dec 2019 | $279.40 K(>+9900.0%) | $279.40 K(>+9900.0%) |
Sept 2019 | - | $0.00(0.0%) |
June 2019 | - | $0.00(0.0%) |
Mar 2019 | - | $0.00(0.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2018 | - | $0.00(0.0%) |
June 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2017 | - | $0.00(0.0%) |
June 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2016 | - | $0.00(0.0%) |
June 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | - | $0.00(0.0%) |
Sept 2015 | - | $0.00(-100.0%) |
June 2015 | $515.00 K(+194.3%) | $515.00 K(>+9900.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | - | $0.00(0.0%) |
Sept 2014 | - | $0.00(-100.0%) |
Date | Annual | Quarterly |
---|---|---|
June 2014 | $175.00 K(>+9900.0%) | $175.00 K(-80.6%) |
June 2013 | $0.00(-100.0%) | - |
Sept 2011 | - | $903.00 K(-0.3%) |
June 2011 | - | $906.00 K(-0.8%) |
Mar 2011 | - | $913.00 K(+0.7%) |
Dec 2010 | $907.00 K(-66.2%) | $907.00 K(-65.7%) |
Sept 2010 | - | $2.64 M(+0.5%) |
June 2010 | - | $2.63 M(+0.2%) |
Mar 2010 | - | $2.62 M(-2.3%) |
Dec 2009 | $2.69 M(+177.1%) | $2.69 M(>+9900.0%) |
Sept 2009 | - | $0.00(0.0%) |
June 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(-100.0%) |
Dec 2008 | $969.00 K(+4304.5%) | $969.00 K(-93.5%) |
Sept 2008 | - | $14.92 M(-22.4%) |
June 2008 | - | $19.21 M(+39.1%) |
Mar 2008 | - | $13.81 M(>+9900.0%) |
Dec 2007 | $22.00 K(+2100.0%) | $22.00 K(-50.0%) |
Sept 2007 | - | $44.00 K(-34.3%) |
June 2007 | - | $67.00 K(-24.7%) |
Mar 2007 | - | $89.00 K(+8800.0%) |
July 2006 | - | $1000.00(>+9900.0%) |
July 2006 | $1000.00(-100.0%) | - |
July 2004 | $3.79 M(>+9900.0%) | - |
Apr 2003 | - | $0.00(0.0%) |
Jan 2003 | - | $0.00(0.0%) |
Oct 2002 | - | $0.00(0.0%) |
July 2002 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2002 | - | $0.00(0.0%) |
Jan 2002 | - | $0.00(0.0%) |
Oct 2001 | - | $0.00(0.0%) |
July 2001 | $0.00(-100.0%) | $0.00(0.0%) |
Apr 2001 | - | $0.00(-100.0%) |
Jan 2001 | - | $264.00 K(-27.5%) |
Oct 2000 | - | $364.00 K(0.0%) |
July 2000 | $364.00 K(>+9900.0%) | $364.00 K(-35.5%) |
Apr 2000 | - | $564.00 K(-15.1%) |
Jan 2000 | - | $664.00 K(>+9900.0%) |
July 1999 | $0.00(0.0%) | $0.00(0.0%) |
July 1998 | $0.00 | $0.00(-100.0%) |
Jan 1997 | - | $100.00 K |
FAQ
- What is Protagenic Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual total long term liabilities year-on-year change?
- What is Protagenic Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly long term liabilities year-on-year change?
What is Protagenic Therapeutics annual total long term liabilities?
The current annual total long term liabilities of PTIX is $0.00
What is the all time high annual total long term liabilities for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual total long term liabilities is $3.79 M
What is Protagenic Therapeutics annual total long term liabilities year-on-year change?
Over the past year, PTIX annual total long term liabilities has changed by $0.00 (0.00%)
What is Protagenic Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of PTIX is $0.00
What is the all time high quarterly long term liabilities for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly total long term liabilities is $19.21 M
What is Protagenic Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, PTIX quarterly total long term liabilities has changed by $0.00 (0.00%)